Zhu, Yonghua <br/><br/>
Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.  [electronic resource] 

 -  Oncogene  Sep 2005 
 - 6555-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1208800  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Animals<br/>Carcinoma, Squamous Cell--genetics<br/>Cell Hypoxia--genetics<br/>Dactinomycin--pharmacology<br/>Enhancer Elements, Genetic<br/>Gene Expression Regulation<br/>Genes, ras<br/>Head and Neck Neoplasms--genetics<br/>Mice<br/>Osteopontin<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-akt<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>RNA Stability<br/>RNA, Messenger--drug effects<br/>Response Elements<br/>Sialoglycoproteins--genetics<br/>Transcription, Genetic